Latest News
FTSE 250 movers: Evraz adds steel, Mitie's mighty fall to 2009 low
The FTSE 250 index on Wednesday recouped its losses from this and last week, led by further gains for miners.
Sector movers: Miners boosted by positive broker views
Shares in miners provided the biggest lift for the market, as at least two more top brokers weighed in with positive views on the space.
hVIVO revises expectations after accounting anomaly
Specialty biopharma company with clinical testing capabilities, hVIVO, announced a trading update regarding the accounting treatment of the company's joint venture investment in Imutex on Wednesday.
CloudTag appoints Yuval Lange as chief business development officer
CloudTag has announced the appointment of Yuval Lange as chief business development officer.
High-income voters turn back on GOP in favour of Clinton
The highest earners in the US appear to be swinging towards a vote for Hillary Clinton in the upcoming presidential election, bringing to an end a long-running tendency for top-earners to vote Republican.
US pharmaceutical company criticised for increasing price of acne cream to $10,000
Novum Pharma has been criticised for bumping up the price of one of its skin creams by over 128%, in the latest instance of so-called "gouging" in the US healthcare market.
WTI oil futures jump after latest US DoE inventory data
US crude oil inventories registered a large fall in the latest week, alongside a large drop in some product stockpiles.
Broker tips: Anglo American, Kaz, Barclays, Ocado
Barclays upgraded Anglo American to ‘equalweight’ from ‘underweight’ and lifted the price target to 845p from 550p on strong valuation support and solid earnings momentum, particularly from the recent rally in coking coal which leaves the balance sheet in a much better position than the bank had expected.
TUI said to launch sale of specialist travel portfolio
Tour operator TUI has reportedly chosen advisors to launch the sale of a portfolio of specialist travel brands in a deal potentially worth up to €600m as it looks to sell its non-core assets.
Target set to authorise $5 billion share buyback deal
United States retailer Target has said it will authorise a $5bn share buyback deal, upon completion of a previous plan.
US open: Stocks rise as traders mull BoJ and await FOMC policy decisions
US stocks gained as traders awaited the Federal Reserve’s policy decision after the Bank of Japan altered its stimulus programme.
Credit Suisse downgrades Imperial Brands, cuts target price
Strained consumer finances and the prospect of stiffer competition in the value segment of the market meant that Imperial Brands's shares were trading at too narrow a discount versus those of British American Tobacco, Credit Suisse said.
International Personal Finance CFO Gardner resigns
International Personal Finance said on Wednesday that is chief financial officer, Adrian Gardner, has resigned "to pursue an alternative business opportunity".
DekelOil swings to profit after record production in first half
Operator and 85. 75% owner of the Ayenouan palm oil project in Côte d'Ivoire, DekelOil Public, announced its interim results for the six months to 30 June on Wednesday, with a record half yearly production of 28,550 tonnes of crude palm oil - up from 21,836 tonnes in the first half of 2015.
Midatech Pharma pens US deal with R-Pharm
International specialty pharmaceutical company Midatech Pharma announced on Wednesday that its US subsidiary, Midatech Pharma US, has finalised a co-promotion agreement with R-Pharm US, providing additional reach and frequency for the promotion the of Zuplenz and Oravig products to oncology accounts across the US.
Credit Suisse reiterates overweight on financials, UK insurers
Credit Suisse reiterated its 'overweight' stance on global financials with a focus on names from retail banking and those issues with exposure to emerging markets.
FTSE 100 movers: It's all about the broker notes
London’s FTSE 100 was up 0. 1% to 6,839. 33 in afternoon trade, with broker notes dominating the movers.
Eleven Biotherapeutics buys Canada's Viventia Bio in all-stock deal
Eleven Biotherapeutics has bought Canada’s Viventia Bio Inc. in an all-stock deal.
MoneySwap shares suspended from trading over results delays
MoneySwap announced on Wednesday that it will not be in a position to publish its audited report and accounts for the year to 31 March by 30 September, in accordance with the AIM Rules for Companies.
Imperial Innovations invests £5.1m in new biotech start-up
AIM-listed technology investor Imperial Innovations invested £5. 1m in Artios Pharma, a new biotech start-up launched on Wednesday.